Ansbert Gadicke's Net Worth
$6.63 Million
Who is Ansbert Gadicke?
Ansbert Gadicke has an estimated net worth of $6.63 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., EnteroMedics Inc, iTeos Therapeutics, Inc., ARYx Therapeutics, Inc., PEPLIN INC, Restore Medical, Inc., CRYOCOR INC, VIACELL INC, HEMOSENSE INC, COTHERIX INC, Omrix Biopharmaceuticals, Inc., TERCICA INC, BARRIER THERAPEUTICS INC, TriVascular Technologies, Inc., RIGEL PHARMACEUTICALS INC, Cullinan Management, Inc., Radius Health, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Dyne Therapeutics, Inc., Allovir, Inc., Verastem, Inc., Syndax Pharmaceuticals Inc, HEALTHCARE ACQUISITION CORP, AVEO PHARMACEUTICALS INC, Pacira Pharmaceuticals, Inc., XCYTE THERAPIES INC, NEORX CORP, Harpoon Therapeutics, Inc., ACORDA THERAPEUTICS INC, ARATANA THERAPEUTICS, INC., KALOBIOS PHARMACEUTICALS INC, TCR2 THERAPEUTICS INC., Conatus Pharmaceuticals Inc, Epizyme, Inc., Werewolf Therapeutics, Inc., Cerecor Inc., Oncorus, Inc., CRITICAL THERAPEUTICS INC, Pharmasset Inc, Zalicus Inc., AFFYMAX INC, CHIASMA, INC, Somaxon Pharmaceuticals, Inc., IDENIX PHARMACEUTICALS INC, HELICOS BIOSCIENCES CORP, SENORX INC, OSCIENT PHARMACEUTICALS CORP, Alsius Corp, MEMORY PHARMACEUTICALS CORP, and METABASIS THERAPEUTICS INC.
SEC CIK
Ansbert Gadicke's CIK is 0001134655
Past Insider Trading and Trends
2021 was Ansbert Gadicke's most active year for acquiring shares with 5 total transactions. Ansbert Gadicke's most active month to acquire stocks was the month of April. 2021 was Ansbert Gadicke's most active year for disposing of shares, totalling 19 transactions. Ansbert Gadicke's most active month to dispose stocks was the month of August. 2021 saw Ansbert Gadicke paying a total of $0.00 for 662,506 shares, this is the most they've acquired in one year. In 2014 Ansbert Gadicke cashed out on 26,713 shares for a total of $538,534.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9,078.27% | 2.67M |
$17.00 |
—
| 2.7M |
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EnteroMedics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +73.01% | 704.61K |
—
|
—
| 1.67M |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +43.86% | 1.77M |
$1.15 | $2,030,323.85 | 5.79M |
Feb 24
| |||
Form 4
|
∞
| 4.03M |
$8.00 |
—
| 4.03M |
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $14.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.19% | -245.47K |
$42.58 | -$10,452,333.95 | 4.48M |
Jan 4 - Jan 5
| |||
Form 4
| -1.73% | -83.39K |
$33.73 | -$2,812,427.53 | 4.73M |
Scheduled
|
Dec 3 - Dec 7
| ||
Form 4
| -2.82% | -139.77K |
$34.47 | -$4,817,417.25 | 4.81M |
Scheduled
|
Nov 30 - Dec 2
| ||
Form 4
| -0.77% | -38.57K |
$35.18 | -$1,356,824.98 | 4.95M |
Scheduled
|
Nov 26 - Nov 29
| ||
Form 4
| -0.95% | -145.29K |
$36.85 | -$4,744,666.44 | 15.22M |
Scheduled
|
Nov 17 - Nov 24
| ||
Form 4
| -0.55% | -28.61K |
$27.45 | -$785,384.39 | 5.14M |
Scheduled
|
Oct 15 - Oct 18
| ||
Form 4
| -1.81% | -95.00K |
$27.21 | -$2,584,606.09 | 5.17M |
Scheduled
|
Oct 12 - Oct 14
| ||
Form 4
| -1.63% | -87.01K |
$27.23 | -$2,368,800.16 | 5.26M |
Scheduled
|
Oct 7 - Oct 11
| ||
Form 4
| -0.86% | -46.13K |
$27.05 | -$1,247,589.54 | 5.35M |
Scheduled
|
Oct 1 - Oct 4
| ||
Form 4
| -0.66% | -35.99K |
$27.00 | -$971,730.00 | 5.39M |
Scheduled
|
Sep 28 - Sep 30
| ||
Form 4
| -1.62% | -89.48K |
$27.76 | -$2,484,093.96 | 5.43M |
Scheduled
|
Sep 23 - Sep 27
| ||
Form 4
| -1.02% | -56.78K |
$27.50 | -$1,561,393.60 | 5.52M |
Scheduled
|
Sep 21 - Sep 22
| ||
Form 4
| -2.67% | -152.71K |
$28.38 | -$4,334,451.90 | 5.58M |
Scheduled
|
Sep 16 - Sep 20
| ||
Form 4
| -1.32% | -76.42K |
$27.70 | -$2,116,733.05 | 5.73M |
Scheduled
|
Sep 14 - Sep 15
| ||
Form 4
| -1.63% | -96.46K |
$28.32 | -$2,731,459.64 | 5.81M |
Scheduled
|
Sep 9 - Sep 13
| ||
Form 4
| -1.71% | -102.57K |
$29.03 | -$2,067,786.01 | 5.9M |
Scheduled
|
Sep 7 - Sep 8
| ||
Form 4
| -0.00% | -200.00 |
$29.99 | -$5,998.00 | 6M |
Scheduled
|
Apr 9
| ||
Form 4
| -0.95% | -57.65K |
$30.99 | -$1,300,850.41 | 6M |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
| +64.51% | 6.06M |
$19.00 | $6,080,000.00 | 15.46M |
Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARYx Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 4
| +49.98% | 1.79M |
$2.20 | $3,932,962.00 | 5.36M |
Nov 14
| |||
Form 4
|
∞
| 3.58M |
$10.00 |
—
| 3.58M |
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PEPLIN INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.42M |
—
|
—
|
0
|
Nov 11
| |||
Form 4
| +0.07% | 2.25K |
$8.11 | $18,233.80 | 3.42M |
Feb 11 - Feb 12
| |||
Form 4
| +0.03% | 1K |
$8.00 | $7,992.00 | 3.42M |
Feb 9
| |||
Form 4
| +0.08% | 2.65K |
$7.80 | $20,654.40 | 3.42M |
Feb 5
| |||
Form 4
| +0.23% | 7.71K |
$8.04 | $61,948.00 | 3.41M |
Jan 23 - Jan 27
| |||
Form 4
| +0.10% | 3.52K |
$8.07 | $28,369.80 | 3.41M |
Jan 21 - Jan 22
| |||
Form 4
| +0.29% | 9.88K |
$8.14 | $80,402.20 | 3.4M |
Jan 15 - Jan 20
| |||
Form 4
| +0.20% | 6.91K |
$7.03 | $48,584.33 | 3.39M |
Jan 13
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||